Table 1: Clinical and laboratory characteristics of the SLE patients studied.

Clinical characteristics

Age, years, mean ± SD
Females, (%)85 (92.4)
SLE diagnosis duration, months (IQR)132 (60–216)
Risk factor for LTBI, (%)9 (9.8)
BCG vaccinated, (%)
 Nonvaccinated90 (97.8)
 Vaccinated2 (2.2)
Treatment regimen, (%)
 <7.5 mg prednisone39 (42.4)
 >7.5 mg prednisone18 (19.6)
 IS drugs37 (40.2)
 Hydroxychloroquine79 (85.9)
SLEDAI, mean ± SD
Laboratory findings
 dsDNAn levels, median (IQR)14.50 (4.77–44.75)
 C3 mg/dL, mean ± SD
 C4 mg/dL, mean ± SD
 Lymphocyte cells/uL, mean ± SD
 CD4 cells/uL, ±SD
CD4 (%)
 ≤200 2.3
 200–50026.1
 ≥50071.6
 CD8 cells/uL, ±SD
 B cells/uL, median (IQR)119.80 (65.35–215.40)
 NK cells/uL, median (IQR)167.50 (110.50–229.90)